» Articles » PMID: 30816332

PIM1 Inhibition Effectively Enhances Plerixafor-induced HSC Mobilization by Counteracting CXCR4 Upregulation and Blocking CXCL12 Secretion

Citing Articles

Beneficial mechanisms of dimethyl fumarate in autoimmune uveitis: insights from single-cell RNA sequencing.

Zhu L, Li H, Peng X, Li Z, Zhao S, Wu D J Neuroinflammation. 2024; 21(1):112.

PMID: 38684986 PMC: 11059727. DOI: 10.1186/s12974-024-03096-6.


Comparison of the efficacy of hematopoietic stem cell mobilization regimens: a systematic review and network meta-analysis of preclinical studies.

Luo C, Wang L, Wu G, Huang X, Zhang Y, Ma Y Stem Cell Res Ther. 2021; 12(1):310.

PMID: 34051862 PMC: 8164253. DOI: 10.1186/s13287-021-02379-6.


Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization.

Chen J, Lazarus H, Dahi P, Avecilla S, Giralt S Blood Rev. 2020; 47:100771.

PMID: 33213986 PMC: 9361219. DOI: 10.1016/j.blre.2020.100771.


Safety, Efficacy, Pharmacokinetic and Pharmacodynamic evaluation of YF-H-2015005 for mobilizing Hematopoietic stem cells in Non-Hodgkin's Lymphoma Patients.

Liu W, Xie Y, Ping L, Jiang M, Zhang G, Cui Y J Cancer. 2020; 11(19):5635-5640.

PMID: 32913458 PMC: 7477452. DOI: 10.7150/jca.48748.

References
1.
Mohle R, Bautz F, Rafii S, Moore M, Brugger W, Kanz L . The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood. 1998; 91(12):4523-30. View